nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—NME2—pineal body—malignant glioma	0.0265	0.0965	CbGeAlD
Lamivudine—PGK1—brainstem—malignant glioma	0.0166	0.0603	CbGeAlD
Lamivudine—PCYT2—central nervous system—malignant glioma	0.00974	0.0354	CbGeAlD
Lamivudine—Opportunistic infection—Temozolomide—malignant glioma	0.00939	0.0339	CcSEcCtD
Lamivudine—NME2—embryo—malignant glioma	0.00903	0.0329	CbGeAlD
Lamivudine—CMPK1—brainstem—malignant glioma	0.00847	0.0308	CbGeAlD
Lamivudine—PGK1—central nervous system—malignant glioma	0.00836	0.0304	CbGeAlD
Lamivudine—NME2—brainstem—malignant glioma	0.00828	0.0301	CbGeAlD
Lamivudine—PGK1—cerebellum—malignant glioma	0.00818	0.0297	CbGeAlD
Lamivudine—NME2—retina—malignant glioma	0.00798	0.029	CbGeAlD
Lamivudine—PCYT2—brain—malignant glioma	0.00773	0.0281	CbGeAlD
Lamivudine—CMPK1—telencephalon—malignant glioma	0.00751	0.0273	CbGeAlD
Lamivudine—NT5C—central nervous system—malignant glioma	0.00706	0.0257	CbGeAlD
Lamivudine—NT5C—cerebellum—malignant glioma	0.0069	0.0251	CbGeAlD
Lamivudine—PGK1—brain—malignant glioma	0.00664	0.0242	CbGeAlD
Lamivudine—PCYT1A—central nervous system—malignant glioma	0.00663	0.0241	CbGeAlD
Lamivudine—NT5C—brain—malignant glioma	0.00561	0.0204	CbGeAlD
Lamivudine—CMPK1—midbrain—malignant glioma	0.0054	0.0196	CbGeAlD
Lamivudine—Myopathy—Temozolomide—malignant glioma	0.00539	0.0195	CcSEcCtD
Lamivudine—CMPK1—spinal cord—malignant glioma	0.00526	0.0192	CbGeAlD
Lamivudine—PCYT1A—brain—malignant glioma	0.00526	0.0191	CbGeAlD
Lamivudine—Hyperaesthesia—Temozolomide—malignant glioma	0.00482	0.0174	CcSEcCtD
Lamivudine—DCK—embryo—malignant glioma	0.0046	0.0167	CbGeAlD
Lamivudine—NME1—central nervous system—malignant glioma	0.00443	0.0161	CbGeAlD
Lamivudine—NME1—cerebellum—malignant glioma	0.00433	0.0158	CbGeAlD
Lamivudine—CMPK1—central nervous system—malignant glioma	0.00427	0.0155	CbGeAlD
Lamivudine—Drug interaction—Carmustine—malignant glioma	0.00422	0.0152	CcSEcCtD
Lamivudine—Viral infection—Temozolomide—malignant glioma	0.00419	0.0151	CcSEcCtD
Lamivudine—CMPK1—cerebellum—malignant glioma	0.00417	0.0152	CbGeAlD
Lamivudine—NME2—central nervous system—malignant glioma	0.00417	0.0152	CbGeAlD
Lamivudine—NME2—cerebellum—malignant glioma	0.00408	0.0148	CbGeAlD
Lamivudine—DCK—retina—malignant glioma	0.00407	0.0148	CbGeAlD
Lamivudine—Hearing impaired—Temozolomide—malignant glioma	0.00397	0.0143	CcSEcCtD
Lamivudine—Musculoskeletal pain—Temozolomide—malignant glioma	0.00383	0.0138	CcSEcCtD
Lamivudine—SLC22A3—embryo—malignant glioma	0.00375	0.0136	CbGeAlD
Lamivudine—DCK—telencephalon—malignant glioma	0.00374	0.0136	CbGeAlD
Lamivudine—Neuropathy—Carmustine—malignant glioma	0.00367	0.0133	CcSEcCtD
Lamivudine—Aplastic anaemia—Temozolomide—malignant glioma	0.00355	0.0128	CcSEcCtD
Lamivudine—Neuropathy—Temozolomide—malignant glioma	0.00355	0.0128	CcSEcCtD
Lamivudine—NME1—brain—malignant glioma	0.00352	0.0128	CbGeAlD
Lamivudine—Gynaecomastia—Carmustine—malignant glioma	0.0035	0.0126	CcSEcCtD
Lamivudine—Sepsis—Carmustine—malignant glioma	0.00339	0.0123	CcSEcCtD
Lamivudine—CMPK1—brain—malignant glioma	0.00339	0.0123	CbGeAlD
Lamivudine—NME2—brain—malignant glioma	0.00331	0.0121	CbGeAlD
Lamivudine—Phlebitis—Carmustine—malignant glioma	0.0033	0.0119	CcSEcCtD
Lamivudine—SLC22A1—telencephalon—malignant glioma	0.00319	0.0116	CbGeAlD
Lamivudine—Gastroenteritis—Temozolomide—malignant glioma	0.0031	0.0112	CcSEcCtD
Lamivudine—Injury—Carmustine—malignant glioma	0.00309	0.0112	CcSEcCtD
Lamivudine—Deafness—Temozolomide—malignant glioma	0.00307	0.0111	CcSEcCtD
Lamivudine—DCK—medulla oblongata—malignant glioma	0.00294	0.0107	CbGeAlD
Lamivudine—Thirst—Temozolomide—malignant glioma	0.00288	0.0104	CcSEcCtD
Lamivudine—Affect lability—Temozolomide—malignant glioma	0.0027	0.00976	CcSEcCtD
Lamivudine—DCK—midbrain—malignant glioma	0.00269	0.00978	CbGeAlD
Lamivudine—Liver function test abnormal—Carmustine—malignant glioma	0.00262	0.00947	CcSEcCtD
Lamivudine—DCK—spinal cord—malignant glioma	0.00262	0.00954	CbGeAlD
Lamivudine—Mood swings—Temozolomide—malignant glioma	0.0026	0.00939	CcSEcCtD
Lamivudine—Dehydration—Temozolomide—malignant glioma	0.00255	0.00922	CcSEcCtD
Lamivudine—ABCC1—telencephalon—malignant glioma	0.00252	0.00917	CbGeAlD
Lamivudine—Muscular weakness—Carmustine—malignant glioma	0.0025	0.00905	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00247	0.00892	CcSEcCtD
Lamivudine—Dysphagia—Carmustine—malignant glioma	0.00245	0.00886	CcSEcCtD
Lamivudine—Muscular weakness—Temozolomide—malignant glioma	0.00242	0.00874	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00242	0.00874	CcSEcCtD
Lamivudine—Abdominal distension—Temozolomide—malignant glioma	0.00239	0.00862	CcSEcCtD
Lamivudine—Dysphagia—Temozolomide—malignant glioma	0.00237	0.00857	CcSEcCtD
Lamivudine—Pancytopenia—Carmustine—malignant glioma	0.00233	0.00842	CcSEcCtD
Lamivudine—Sweating increased—Temozolomide—malignant glioma	0.00231	0.00834	CcSEcCtD
Lamivudine—Neutropenia—Carmustine—malignant glioma	0.0023	0.00829	CcSEcCtD
Lamivudine—Bronchitis—Temozolomide—malignant glioma	0.00228	0.00824	CcSEcCtD
Lamivudine—Pancytopenia—Temozolomide—malignant glioma	0.00225	0.00813	CcSEcCtD
Lamivudine—Neutropenia—Temozolomide—malignant glioma	0.00222	0.00801	CcSEcCtD
Lamivudine—Dysuria—Temozolomide—malignant glioma	0.00222	0.00801	CcSEcCtD
Lamivudine—Hyperglycaemia—Carmustine—malignant glioma	0.00221	0.008	CcSEcCtD
Lamivudine—SLC22A6—brain—malignant glioma	0.00221	0.00805	CbGeAlD
Lamivudine—Pollakiuria—Temozolomide—malignant glioma	0.00219	0.00791	CcSEcCtD
Lamivudine—Depression—Carmustine—malignant glioma	0.00218	0.00788	CcSEcCtD
Lamivudine—Renal failure—Carmustine—malignant glioma	0.00215	0.00777	CcSEcCtD
Lamivudine—Neuropathy peripheral—Carmustine—malignant glioma	0.00215	0.00775	CcSEcCtD
Lamivudine—Hyperglycaemia—Temozolomide—malignant glioma	0.00214	0.00773	CcSEcCtD
Lamivudine—Stomatitis—Carmustine—malignant glioma	0.00213	0.0077	CcSEcCtD
Lamivudine—DCK—central nervous system—malignant glioma	0.00213	0.00774	CbGeAlD
Lamivudine—ABCB1—blood vessel—malignant glioma	0.00212	0.00772	CbGeAlD
Lamivudine—Depression—Temozolomide—malignant glioma	0.00211	0.00762	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0021	0.00757	CcSEcCtD
Lamivudine—ABCG2—telencephalon—malignant glioma	0.00209	0.00759	CbGeAlD
Lamivudine—DCK—cerebellum—malignant glioma	0.00208	0.00756	CbGeAlD
Lamivudine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00207	0.00749	CcSEcCtD
Lamivudine—Stomatitis—Temozolomide—malignant glioma	0.00206	0.00744	CcSEcCtD
Lamivudine—ABCC3—central nervous system—malignant glioma	0.00204	0.00741	CbGeAlD
Lamivudine—Hepatobiliary disease—Temozolomide—malignant glioma	0.002	0.00722	CcSEcCtD
Lamivudine—Sinusitis—Temozolomide—malignant glioma	0.00198	0.00717	CcSEcCtD
Lamivudine—Hypoaesthesia—Carmustine—malignant glioma	0.00195	0.00706	CcSEcCtD
Lamivudine—Connective tissue disorder—Carmustine—malignant glioma	0.00193	0.00697	CcSEcCtD
Lamivudine—Hepatitis—Temozolomide—malignant glioma	0.0019	0.00686	CcSEcCtD
Lamivudine—Hypoaesthesia—Temozolomide—malignant glioma	0.00189	0.00682	CcSEcCtD
Lamivudine—Pharyngitis—Temozolomide—malignant glioma	0.00188	0.0068	CcSEcCtD
Lamivudine—Connective tissue disorder—Temozolomide—malignant glioma	0.00187	0.00674	CcSEcCtD
Lamivudine—SLC22A1—central nervous system—malignant glioma	0.00181	0.0066	CbGeAlD
Lamivudine—Erythema multiforme—Temozolomide—malignant glioma	0.00179	0.00648	CcSEcCtD
Lamivudine—Alopecia—Carmustine—malignant glioma	0.00174	0.00627	CcSEcCtD
Lamivudine—SLC22A3—central nervous system—malignant glioma	0.00173	0.00631	CbGeAlD
Lamivudine—Immune system disorder—Temozolomide—malignant glioma	0.00171	0.00619	CcSEcCtD
Lamivudine—Mediastinal disorder—Temozolomide—malignant glioma	0.00171	0.00618	CcSEcCtD
Lamivudine—Malnutrition—Carmustine—malignant glioma	0.00171	0.00618	CcSEcCtD
Lamivudine—Erythema—Carmustine—malignant glioma	0.00171	0.00618	CcSEcCtD
Lamivudine—Chills—Temozolomide—malignant glioma	0.0017	0.00615	CcSEcCtD
Lamivudine—DCK—brain—malignant glioma	0.00169	0.00614	CbGeAlD
Lamivudine—ABCC4—central nervous system—malignant glioma	0.00168	0.00612	CbGeAlD
Lamivudine—Alopecia—Temozolomide—malignant glioma	0.00168	0.00606	CcSEcCtD
Lamivudine—Back pain—Carmustine—malignant glioma	0.00165	0.00597	CcSEcCtD
Lamivudine—Erythema—Temozolomide—malignant glioma	0.00165	0.00597	CcSEcCtD
Lamivudine—Malnutrition—Temozolomide—malignant glioma	0.00165	0.00597	CcSEcCtD
Lamivudine—ABCG2—medulla oblongata—malignant glioma	0.00164	0.00597	CbGeAlD
Lamivudine—Dysgeusia—Temozolomide—malignant glioma	0.00162	0.00584	CcSEcCtD
Lamivudine—ABCC3—brain—malignant glioma	0.00162	0.00588	CbGeAlD
Lamivudine—Tremor—Carmustine—malignant glioma	0.0016	0.00579	CcSEcCtD
Lamivudine—Back pain—Temozolomide—malignant glioma	0.0016	0.00577	CcSEcCtD
Lamivudine—Anaemia—Carmustine—malignant glioma	0.00158	0.00571	CcSEcCtD
Lamivudine—Tremor—Temozolomide—malignant glioma	0.00155	0.00559	CcSEcCtD
Lamivudine—Ill-defined disorder—Temozolomide—malignant glioma	0.00153	0.00554	CcSEcCtD
Lamivudine—Leukopenia—Carmustine—malignant glioma	0.00153	0.00553	CcSEcCtD
Lamivudine—Anaemia—Temozolomide—malignant glioma	0.00153	0.00552	CcSEcCtD
Lamivudine—Angioedema—Temozolomide—malignant glioma	0.00151	0.00545	CcSEcCtD
Lamivudine—ABCG2—midbrain—malignant glioma	0.0015	0.00545	CbGeAlD
Lamivudine—Malaise—Temozolomide—malignant glioma	0.00149	0.00538	CcSEcCtD
Lamivudine—Vertigo—Temozolomide—malignant glioma	0.00148	0.00536	CcSEcCtD
Lamivudine—Convulsion—Carmustine—malignant glioma	0.00148	0.00535	CcSEcCtD
Lamivudine—Leukopenia—Temozolomide—malignant glioma	0.00148	0.00534	CcSEcCtD
Lamivudine—ABCG2—spinal cord—malignant glioma	0.00146	0.00532	CbGeAlD
Lamivudine—Chest pain—Carmustine—malignant glioma	0.00146	0.00526	CcSEcCtD
Lamivudine—Myalgia—Carmustine—malignant glioma	0.00146	0.00526	CcSEcCtD
Lamivudine—Anxiety—Carmustine—malignant glioma	0.00145	0.00524	CcSEcCtD
Lamivudine—Cough—Temozolomide—malignant glioma	0.00144	0.00521	CcSEcCtD
Lamivudine—SLC22A1—brain—malignant glioma	0.00144	0.00524	CbGeAlD
Lamivudine—Convulsion—Temozolomide—malignant glioma	0.00143	0.00517	CcSEcCtD
Lamivudine—Confusional state—Carmustine—malignant glioma	0.00141	0.00508	CcSEcCtD
Lamivudine—Myalgia—Temozolomide—malignant glioma	0.00141	0.00508	CcSEcCtD
Lamivudine—Arthralgia—Temozolomide—malignant glioma	0.00141	0.00508	CcSEcCtD
Lamivudine—Anxiety—Temozolomide—malignant glioma	0.0014	0.00506	CcSEcCtD
Lamivudine—ABCC1—cerebellum—malignant glioma	0.0014	0.0051	CbGeAlD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0014	0.00505	CcSEcCtD
Lamivudine—Oedema—Carmustine—malignant glioma	0.0014	0.00504	CcSEcCtD
Lamivudine—Discomfort—Temozolomide—malignant glioma	0.00139	0.00502	CcSEcCtD
Lamivudine—Infection—Carmustine—malignant glioma	0.00139	0.00501	CcSEcCtD
Lamivudine—SLC22A3—brain—malignant glioma	0.00138	0.00501	CbGeAlD
Lamivudine—Dry mouth—Temozolomide—malignant glioma	0.00138	0.00497	CcSEcCtD
Lamivudine—Thrombocytopenia—Carmustine—malignant glioma	0.00137	0.00494	CcSEcCtD
Lamivudine—Confusional state—Temozolomide—malignant glioma	0.00136	0.00491	CcSEcCtD
Lamivudine—Oedema—Temozolomide—malignant glioma	0.00135	0.00487	CcSEcCtD
Lamivudine—Anaphylactic shock—Temozolomide—malignant glioma	0.00135	0.00487	CcSEcCtD
Lamivudine—Infection—Temozolomide—malignant glioma	0.00134	0.00484	CcSEcCtD
Lamivudine—ABCC4—brain—malignant glioma	0.00133	0.00485	CbGeAlD
Lamivudine—Anorexia—Carmustine—malignant glioma	0.00133	0.0048	CcSEcCtD
Lamivudine—Nervous system disorder—Temozolomide—malignant glioma	0.00132	0.00478	CcSEcCtD
Lamivudine—Thrombocytopenia—Temozolomide—malignant glioma	0.00132	0.00477	CcSEcCtD
Lamivudine—Skin disorder—Temozolomide—malignant glioma	0.00131	0.00473	CcSEcCtD
Lamivudine—Hypotension—Carmustine—malignant glioma	0.0013	0.00471	CcSEcCtD
Lamivudine—Hyperhidrosis—Temozolomide—malignant glioma	0.0013	0.00471	CcSEcCtD
Lamivudine—Anorexia—Temozolomide—malignant glioma	0.00129	0.00464	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00127	0.00459	CcSEcCtD
Lamivudine—ABCB1—embryo—malignant glioma	0.00127	0.0046	CbGeAlD
Lamivudine—Insomnia—Carmustine—malignant glioma	0.00126	0.00456	CcSEcCtD
Lamivudine—Paraesthesia—Carmustine—malignant glioma	0.00125	0.00453	CcSEcCtD
Lamivudine—Dyspnoea—Carmustine—malignant glioma	0.00124	0.00449	CcSEcCtD
Lamivudine—Somnolence—Carmustine—malignant glioma	0.00124	0.00448	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00123	0.00444	CcSEcCtD
Lamivudine—Insomnia—Temozolomide—malignant glioma	0.00122	0.00441	CcSEcCtD
Lamivudine—Decreased appetite—Carmustine—malignant glioma	0.00121	0.00438	CcSEcCtD
Lamivudine—Paraesthesia—Temozolomide—malignant glioma	0.00121	0.00437	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Carmustine—malignant glioma	0.0012	0.00435	CcSEcCtD
Lamivudine—Dyspnoea—Temozolomide—malignant glioma	0.0012	0.00434	CcSEcCtD
Lamivudine—Somnolence—Temozolomide—malignant glioma	0.0012	0.00433	CcSEcCtD
Lamivudine—Constipation—Carmustine—malignant glioma	0.00119	0.00431	CcSEcCtD
Lamivudine—Pain—Carmustine—malignant glioma	0.00119	0.00431	CcSEcCtD
Lamivudine—Dyspepsia—Temozolomide—malignant glioma	0.00119	0.00429	CcSEcCtD
Lamivudine—Decreased appetite—Temozolomide—malignant glioma	0.00117	0.00423	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00116	0.00421	CcSEcCtD
Lamivudine—Fatigue—Temozolomide—malignant glioma	0.00116	0.0042	CcSEcCtD
Lamivudine—ABCG2—cerebellum—malignant glioma	0.00116	0.00422	CbGeAlD
Lamivudine—Constipation—Temozolomide—malignant glioma	0.00115	0.00417	CcSEcCtD
Lamivudine—Pain—Temozolomide—malignant glioma	0.00115	0.00417	CcSEcCtD
Lamivudine—Feeling abnormal—Carmustine—malignant glioma	0.00115	0.00415	CcSEcCtD
Lamivudine—Gastrointestinal pain—Carmustine—malignant glioma	0.00114	0.00412	CcSEcCtD
Lamivudine—ABCC1—brain—malignant glioma	0.00114	0.00414	CbGeAlD
Lamivudine—ABCB1—retina—malignant glioma	0.00112	0.00407	CbGeAlD
Lamivudine—Feeling abnormal—Temozolomide—malignant glioma	0.00111	0.00401	CcSEcCtD
Lamivudine—Body temperature increased—Carmustine—malignant glioma	0.0011	0.00398	CcSEcCtD
Lamivudine—Abdominal pain—Carmustine—malignant glioma	0.0011	0.00398	CcSEcCtD
Lamivudine—Gastrointestinal pain—Temozolomide—malignant glioma	0.0011	0.00398	CcSEcCtD
Lamivudine—Urticaria—Temozolomide—malignant glioma	0.00107	0.00387	CcSEcCtD
Lamivudine—Abdominal pain—Temozolomide—malignant glioma	0.00107	0.00385	CcSEcCtD
Lamivudine—Body temperature increased—Temozolomide—malignant glioma	0.00107	0.00385	CcSEcCtD
Lamivudine—ABCB1—telencephalon—malignant glioma	0.00103	0.00375	CbGeAlD
Lamivudine—Hypersensitivity—Carmustine—malignant glioma	0.00103	0.00371	CcSEcCtD
Lamivudine—Asthenia—Carmustine—malignant glioma	0.001	0.00362	CcSEcCtD
Lamivudine—Hypersensitivity—Temozolomide—malignant glioma	0.000994	0.00359	CcSEcCtD
Lamivudine—Asthenia—Temozolomide—malignant glioma	0.000968	0.00349	CcSEcCtD
Lamivudine—Diarrhoea—Carmustine—malignant glioma	0.000955	0.00345	CcSEcCtD
Lamivudine—Pruritus—Temozolomide—malignant glioma	0.000954	0.00345	CcSEcCtD
Lamivudine—ABCG2—brain—malignant glioma	0.000942	0.00343	CbGeAlD
Lamivudine—Dizziness—Carmustine—malignant glioma	0.000923	0.00333	CcSEcCtD
Lamivudine—Diarrhoea—Temozolomide—malignant glioma	0.000923	0.00333	CcSEcCtD
Lamivudine—Dizziness—Temozolomide—malignant glioma	0.000892	0.00322	CcSEcCtD
Lamivudine—Vomiting—Carmustine—malignant glioma	0.000887	0.0032	CcSEcCtD
Lamivudine—Rash—Carmustine—malignant glioma	0.00088	0.00318	CcSEcCtD
Lamivudine—Dermatitis—Carmustine—malignant glioma	0.000879	0.00318	CcSEcCtD
Lamivudine—Headache—Carmustine—malignant glioma	0.000874	0.00316	CcSEcCtD
Lamivudine—Vomiting—Temozolomide—malignant glioma	0.000858	0.0031	CcSEcCtD
Lamivudine—Rash—Temozolomide—malignant glioma	0.00085	0.00307	CcSEcCtD
Lamivudine—Dermatitis—Temozolomide—malignant glioma	0.00085	0.00307	CcSEcCtD
Lamivudine—Headache—Temozolomide—malignant glioma	0.000845	0.00305	CcSEcCtD
Lamivudine—Nausea—Carmustine—malignant glioma	0.000829	0.00299	CcSEcCtD
Lamivudine—ABCB1—medulla oblongata—malignant glioma	0.000809	0.00294	CbGeAlD
Lamivudine—Nausea—Temozolomide—malignant glioma	0.000801	0.00289	CcSEcCtD
Lamivudine—ABCB1—midbrain—malignant glioma	0.000739	0.00269	CbGeAlD
Lamivudine—ABCB1—spinal cord—malignant glioma	0.000721	0.00262	CbGeAlD
Lamivudine—ABCB1—central nervous system—malignant glioma	0.000585	0.00213	CbGeAlD
Lamivudine—ABCB1—cerebellum—malignant glioma	0.000572	0.00208	CbGeAlD
Lamivudine—ABCB1—brain—malignant glioma	0.000464	0.00169	CbGeAlD
Lamivudine—ABCC1—Metabolism—SPHK1—malignant glioma	8.92e-05	0.000199	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—malignant glioma	8.88e-05	0.000198	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2B6—malignant glioma	8.87e-05	0.000198	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	8.83e-05	0.000197	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2B6—malignant glioma	8.78e-05	0.000196	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP2C18—malignant glioma	8.74e-05	0.000195	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—IDH2—malignant glioma	8.7e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CD—malignant glioma	8.7e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	8.55e-05	0.000191	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—BCHE—malignant glioma	8.55e-05	0.000191	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MDM2—malignant glioma	8.48e-05	0.000189	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—RAF1—malignant glioma	8.45e-05	0.000189	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	8.45e-05	0.000189	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS1—malignant glioma	8.45e-05	0.000189	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC5A5—malignant glioma	8.44e-05	0.000188	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.42e-05	0.000188	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.24e-05	0.000184	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CB—malignant glioma	8.21e-05	0.000183	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2B6—malignant glioma	8.18e-05	0.000182	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—malignant glioma	8.13e-05	0.000181	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—IDH1—malignant glioma	8.11e-05	0.000181	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CAV1—malignant glioma	8.07e-05	0.00018	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—IDH1—malignant glioma	8.03e-05	0.000179	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COX8A—malignant glioma	7.91e-05	0.000177	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—BCHE—malignant glioma	7.86e-05	0.000175	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SPHK1—malignant glioma	7.85e-05	0.000175	CbGpPWpGaD
Lamivudine—ABCC1—Disease—H3F3A—malignant glioma	7.83e-05	0.000175	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—malignant glioma	7.78e-05	0.000174	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—malignant glioma	7.78e-05	0.000174	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—malignant glioma	7.78e-05	0.000174	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—RAF1—malignant glioma	7.78e-05	0.000173	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SPHK1—malignant glioma	7.77e-05	0.000173	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—malignant glioma	7.77e-05	0.000173	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—RAF1—malignant glioma	7.76e-05	0.000173	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC5A5—malignant glioma	7.76e-05	0.000173	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2C18—malignant glioma	7.69e-05	0.000172	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	7.63e-05	0.00017	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2C18—malignant glioma	7.61e-05	0.00017	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CB—malignant glioma	7.58e-05	0.000169	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—malignant glioma	7.58e-05	0.000169	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.5e-05	0.000167	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—IDH1—malignant glioma	7.48e-05	0.000167	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JAG1—malignant glioma	7.38e-05	0.000165	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CG—malignant glioma	7.35e-05	0.000164	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.34e-05	0.000164	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—malignant glioma	7.32e-05	0.000163	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.27e-05	0.000162	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.24e-05	0.000162	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SPHK1—malignant glioma	7.24e-05	0.000161	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FBXW7—malignant glioma	7.23e-05	0.000161	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—malignant glioma	7.22e-05	0.000161	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	7.2e-05	0.000161	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—RAF1—malignant glioma	7.15e-05	0.000159	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTEN—malignant glioma	7.09e-05	0.000158	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—malignant glioma	7.09e-05	0.000158	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2C18—malignant glioma	7.09e-05	0.000158	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTT1—malignant glioma	7.07e-05	0.000158	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—malignant glioma	6.96e-05	0.000155	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	6.83e-05	0.000152	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTP1—malignant glioma	6.8e-05	0.000152	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	6.73e-05	0.00015	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ASMT—malignant glioma	6.73e-05	0.00015	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.73e-05	0.00015	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—RAF1—malignant glioma	6.72e-05	0.00015	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	6.71e-05	0.00015	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	6.64e-05	0.000148	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS1—malignant glioma	6.62e-05	0.000148	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CAT—malignant glioma	6.62e-05	0.000148	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—malignant glioma	6.6e-05	0.000147	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.6e-05	0.000147	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	6.49e-05	0.000145	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CD—malignant glioma	6.46e-05	0.000144	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—malignant glioma	6.34e-05	0.000142	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.34e-05	0.000141	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BCAN—malignant glioma	6.33e-05	0.000141	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTP1—malignant glioma	6.25e-05	0.000139	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NCOR1—malignant glioma	6.25e-05	0.000139	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTT1—malignant glioma	6.22e-05	0.000139	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.18e-05	0.000138	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—BCHE—malignant glioma	6.16e-05	0.000137	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTT1—malignant glioma	6.15e-05	0.000137	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CAT—malignant glioma	6.08e-05	0.000136	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC5A5—malignant glioma	6.08e-05	0.000136	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	6.03e-05	0.000134	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—malignant glioma	5.92e-05	0.000132	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—malignant glioma	5.9e-05	0.000132	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.88e-05	0.000131	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	5.85e-05	0.000131	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS1—malignant glioma	5.83e-05	0.00013	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS1—malignant glioma	5.77e-05	0.000129	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.75e-05	0.000128	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NCOR1—malignant glioma	5.74e-05	0.000128	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTT1—malignant glioma	5.74e-05	0.000128	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.7e-05	0.000127	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	5.67e-05	0.000126	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN2B—malignant glioma	5.67e-05	0.000126	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.66e-05	0.000126	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CB—malignant glioma	5.63e-05	0.000126	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.6e-05	0.000125	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—malignant glioma	5.58e-05	0.000124	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—BCHE—malignant glioma	5.42e-05	0.000121	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HES1—malignant glioma	5.41e-05	0.000121	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—malignant glioma	5.39e-05	0.00012	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS1—malignant glioma	5.37e-05	0.00012	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NCOR1—malignant glioma	5.37e-05	0.00012	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—BCHE—malignant glioma	5.36e-05	0.00012	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC5A5—malignant glioma	5.35e-05	0.000119	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC5A5—malignant glioma	5.3e-05	0.000118	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFRA—malignant glioma	5.15e-05	0.000115	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.11e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH2—malignant glioma	5.1e-05	0.000114	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CAV1—malignant glioma	5.09e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—malignant glioma	5.03e-05	0.000112	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—malignant glioma	5e-05	0.000112	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—BCHE—malignant glioma	5e-05	0.000111	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.97e-05	0.000111	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC5A5—malignant glioma	4.94e-05	0.00011	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.93e-05	0.00011	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—malignant glioma	4.9e-05	0.000109	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.88e-05	0.000109	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—malignant glioma	4.87e-05	0.000109	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2B6—malignant glioma	4.79e-05	0.000107	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAT—malignant glioma	4.77e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HLA-A—malignant glioma	4.74e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—malignant glioma	4.74e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.7e-05	0.000105	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CAV1—malignant glioma	4.68e-05	0.000104	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—malignant glioma	4.64e-05	0.000104	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFB—malignant glioma	4.62e-05	0.000103	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—malignant glioma	4.62e-05	0.000103	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.6e-05	0.000103	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR1—malignant glioma	4.6e-05	0.000103	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.55e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—malignant glioma	4.53e-05	0.000101	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NCOR1—malignant glioma	4.5e-05	0.0001	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—malignant glioma	4.48e-05	9.99e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.47e-05	9.98e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—malignant glioma	4.47e-05	9.97e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH1—malignant glioma	4.38e-05	9.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.38e-05	9.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CAV1—malignant glioma	4.38e-05	9.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.35e-05	9.7e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—malignant glioma	4.31e-05	9.61e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—malignant glioma	4.27e-05	9.52e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—malignant glioma	4.27e-05	9.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SPHK1—malignant glioma	4.24e-05	9.47e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAT—malignant glioma	4.19e-05	9.36e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2C18—malignant glioma	4.16e-05	9.27e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAT—malignant glioma	4.15e-05	9.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BAD—malignant glioma	4.12e-05	9.19e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—malignant glioma	4.12e-05	9.18e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—malignant glioma	4.09e-05	9.12e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOTCH1—malignant glioma	4.08e-05	9.1e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—malignant glioma	4.08e-05	9.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD80—malignant glioma	4e-05	8.92e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.99e-05	8.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—malignant glioma	3.99e-05	8.9e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—malignant glioma	3.98e-05	8.87e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NCOR1—malignant glioma	3.96e-05	8.84e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGF—malignant glioma	3.94e-05	8.8e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTPN11—malignant glioma	3.92e-05	8.75e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NCOR1—malignant glioma	3.92e-05	8.74e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAT—malignant glioma	3.87e-05	8.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.86e-05	8.62e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—malignant glioma	3.77e-05	8.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—malignant glioma	3.75e-05	8.37e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—malignant glioma	3.75e-05	8.36e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAV1—malignant glioma	3.67e-05	8.19e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NCOR1—malignant glioma	3.65e-05	8.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT2—malignant glioma	3.65e-05	8.15e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—malignant glioma	3.56e-05	7.93e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—malignant glioma	3.52e-05	7.86e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—malignant glioma	3.51e-05	7.83e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.51e-05	7.82e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—malignant glioma	3.43e-05	7.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—malignant glioma	3.36e-05	7.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF2—malignant glioma	3.36e-05	7.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—malignant glioma	3.34e-05	7.46e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—malignant glioma	3.27e-05	7.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.26e-05	7.28e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—malignant glioma	3.24e-05	7.22e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAV1—malignant glioma	3.23e-05	7.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—malignant glioma	3.23e-05	7.2e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAV1—malignant glioma	3.2e-05	7.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS1—malignant glioma	3.15e-05	7.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MDM2—malignant glioma	3.14e-05	7.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAF1—malignant glioma	3.13e-05	6.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—malignant glioma	3.1e-05	6.91e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—malignant glioma	3.07e-05	6.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—malignant glioma	3.06e-05	6.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—malignant glioma	3.03e-05	6.76e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAV1—malignant glioma	2.98e-05	6.64e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—malignant glioma	2.94e-05	6.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—malignant glioma	2.94e-05	6.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BCHE—malignant glioma	2.93e-05	6.53e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—malignant glioma	2.91e-05	6.49e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A5—malignant glioma	2.89e-05	6.45e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—malignant glioma	2.84e-05	6.33e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—malignant glioma	2.82e-05	6.3e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—malignant glioma	2.81e-05	6.27e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—malignant glioma	2.8e-05	6.26e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—malignant glioma	2.71e-05	6.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.66e-05	5.94e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—malignant glioma	2.64e-05	5.89e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—malignant glioma	2.62e-05	5.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—malignant glioma	2.59e-05	5.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—malignant glioma	2.56e-05	5.71e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—malignant glioma	2.56e-05	5.71e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—malignant glioma	2.54e-05	5.66e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—malignant glioma	2.38e-05	5.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—malignant glioma	2.36e-05	5.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—malignant glioma	2.33e-05	5.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAT—malignant glioma	2.27e-05	5.06e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—malignant glioma	2.25e-05	5.03e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—malignant glioma	2.23e-05	4.98e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—malignant glioma	2.23e-05	4.98e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—malignant glioma	2.21e-05	4.94e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—malignant glioma	2.21e-05	4.93e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—malignant glioma	2.2e-05	4.9e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—malignant glioma	2.17e-05	4.84e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—malignant glioma	2.15e-05	4.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOR1—malignant glioma	2.14e-05	4.78e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—malignant glioma	2.08e-05	4.64e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—malignant glioma	2.06e-05	4.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—malignant glioma	2.03e-05	4.53e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—malignant glioma	1.99e-05	4.44e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—malignant glioma	1.95e-05	4.34e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—malignant glioma	1.93e-05	4.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—malignant glioma	1.86e-05	4.16e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—malignant glioma	1.8e-05	4.01e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—malignant glioma	1.77e-05	3.95e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAV1—malignant glioma	1.75e-05	3.89e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—malignant glioma	1.63e-05	3.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—malignant glioma	1.59e-05	3.55e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—malignant glioma	1.56e-05	3.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—malignant glioma	1.53e-05	3.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—malignant glioma	1.52e-05	3.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—malignant glioma	1.4e-05	3.12e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—malignant glioma	1.37e-05	3.06e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—malignant glioma	1.36e-05	3.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—malignant glioma	1.28e-05	2.85e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.27e-05	2.83e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—malignant glioma	1.22e-05	2.72e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—malignant glioma	1.21e-05	2.69e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—malignant glioma	1.12e-05	2.5e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—malignant glioma	1.11e-05	2.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—malignant glioma	1.05e-05	2.35e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—malignant glioma	1.04e-05	2.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—malignant glioma	7.43e-06	1.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—malignant glioma	6.07e-06	1.35e-05	CbGpPWpGaD
